content
This website is intended for use by patients prescribed Somavert (pegvisomant) in the UK, and has been developed and funded by Pfizer Ltd.
This information is not intended to be a substitute for advice provided by a healthcare professional. For advice, please consult a healthcare professional.
Adverse event reporting statement can be found at the bottom of this page.
This information is not intended to be a substitute for advice provided by a healthcare professional. For advice, please consult a healthcare professional.
Adverse event reporting statement can be found at the bottom of this page.
image
eyebrow
headline
Somavert Device Support
content
buttons
disclaimer
placeholder_icon
placeholder_title
placeholder_body
headline
Somavert Device Demonstration Video
video_id
account_id
1852113022001
title
Somavert Device Demonstration Video
poster
load
fast
content
buttons
disclaimer
headline
Downloadable User Guide
content
eyebrow
disclaimer
If you have any further questions relating to your medication or device, please speak to your doctor, nurse or pharmacist.
heading
How to use Somavert
body
Click here to read step-by-step instructions on how to use inject Somavert and frequently asked questions.
headline
content
Adverse Event Reporting
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Any suspected side effects may also be reported to Pfizer medical information on 01304 616161. By reporting side effects, you can help provide more information to the safety of this medicine.